We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Sweat-Sensing Fingertip Patch Continuously Tracks Parkinson’s Medication Levels

By HospiMedica International staff writers
Posted on 31 Jul 2026

Parkinson’s disease is a progressive neurodegenerative disorder that disrupts motor control and daily functioning. More...

Clinicians rely on levodopa to manage symptoms, yet dosing is difficult as therapeutic effects fluctuate and narrow over time. Current adjustments often depend on patient diaries and delayed laboratory testing, which can miss dangerous dosing gaps. To help address this challenge, engineers and neuroscientists have developed a wearable fingertip patch that continuously tracks medication levels using a patient’s sweat.

Developed at the University of California San Diego, the soft fingertip patch monitors levodopa, the gold-standard therapy for Parkinson’s disease. The device integrates a flexible printed circuit board with a fingertip patch that houses a sweat-collecting hydrogel, a levodopa sensor, and a paper fluidic channel. The engineering team at the UC San Diego Jacobs School of Engineering collaborated with the Department of Neurosciences at the UC San Diego School of Medicine.

The fingertip has a high density of sweat glands, enabling continuous sample collection. A specially engineered absorbent gel functions as a sweat sponge by using a highly concentrated mixture of salts and benign solvents to draw fluid from pores. When levodopa in sweat contacts enzymes embedded in the patch, a chemical reaction generates a measurable voltage that powers the device and reflects drug concentration, with lower voltage indicating low levels and higher voltage indicating high levels.

In clinical tests involving healthy volunteers and people with Parkinson’s disease, the patch tracked levodopa levels as accurately as standard laboratory blood tests that typically take days to return results. The data showed that individuals with Parkinson’s clear levodopa significantly faster than healthy individuals, which helps explain the abrupt return of symptoms observed in practice. These findings support real-time assessment of therapeutic windows during daily life.

Results were published in Proceedings of the National Academy of Sciences. The technology lays the groundwork for a closed-loop system in which a levodopa monitoring patch could communicate with a pump to deliver precise doses when needed. A complementary microneedle-based wearable approach to continuous levodopa monitoring was recently reported in ACS Sensors.

Related Links
University of California San Diego


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Preoperative Skin Preparation
BD ChloraPrep
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.